최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, v.35 no.1, 2012년, pp.77 - 85
Park, Hye Ri (Department of Bioscience and Biotechnology, Bio) , Yoon, Hyunjun (Department of Bioscience and Biotechnology, Bio) , Kim, Mi Kyoung (Department of Bioscience and Biotechnology, Bio) , Lee, Sung Dae (Swine Science Division, National Institute of Animal Science, RDA) , Chong, Youhoon (Department of Bioscience and Biotechnology, Bio)
Aryl diketoacid (ADK) is well known for antiviral activity which can be enhanced by introduction of an aromatic arylmethyl substituent. A natural flavonoid quercetin has a 3,5-dihydroxychromone pharmacophore which is in bioisosteric relationship with the 1,3-diketoacid moiety of the ADK. Thus, it wa...
Amoros M. Simos C. M. O. Girre L. Sauvager F. Cormier M. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis J. Nat. Prod. 1992 55 1732 1740 10.1021/np50090a003 1338212
Ferry D. R. Smith A. Malkhandi J. Fyfe D. W. de Takats P. G. Anderson D. Baker J. Kerr D. J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin. Cancer Res. 1996 2 659 668 9816216
Gozdek A. Zhukov I. Polkowska A. Poznanski J. Stankiewicz-Drogon A. Pawlowicz J. M. Zagorski-Ostoja W. Borowski P. Boguszewska-Chachulska A. NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: Its mechanism of action and antiviral activity in the replicon system Antimicrob. Agents Chemother. 2008 52 393 401 10.1128/AAC.00961-07 18039921
Harada S. Haneda E. Maekawa T. Morikawa Y. Funayama S. Nagata N. Ohtsuki K. Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro Biol. Pharm. Bull. 1999 22 1122 1126 10.1248/bpb.22.1122 10549869
Kaul T. N. Middleton E. Jr. Ogra P. L. Antiviral effect of flavonoids on human viruses J. Med. Virol. 1985 15 71 79 10.1002/jmv.1890150110 2981979
Kim J. Kim K.-S. Lee H. S. Park K.-S. Park S. Y. Kang S.-Y. Lee S. J. Park H. S. Kim D.-E. Chong Y. Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues Bioorg. Med. Chem. Lett. 2008 18 4661 4665 10.1016/j.bmcl.2008.07.008 18644717
Lamson D. W. Brignall M. S. Antioxidant and cancer III: quercetin Altern. Med. Rev. 2000 5 196 208 10869101
Lee C. Lee J. M. Lee N.-R. Kim D.-E. Jeong Y.-J. Chong Y. Investigation of the pharmacophore space of severe acute respiratory syndrome coronavirus (SARSCoV) NTPase/helicase by dihydroxychromone derivatives Bioorg. Med. Chem. Lett. 2009 19 4538 4541 10.1016/j.bmcl.2009.07.009 19625187
Lee C. Lee J. M. Lee N.-R. Jin B.-S. Jang K. J. Kim D.-E. Jeong Y.-J. Chong Y. Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase Bioorg. Med. Chem. Lett. 2009 19 1636 1638 10.1016/j.bmcl.2009.02.010 19233643
Lee H. S. Park K.-S. Lee C. Lee B. Kim D.-E. Chong Y. 7- O -Arylmethylgalangin as a novel scaffold for anti-HCV agents Bioorg. Med. Chem. Lett. 2010 20 5709 5712 10.1016/j.bmcl.2010.08.012 20797857
Li M. Han X. Yu B. Facile synthesis of flavonoid 7-Oglycosides J. Org. Chem. 2003 68 6842 6845 10.1021/jo034553e 12919064
Lohmann V. Korner F. Koch J. Herian U. Theilmann L. Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 1999 285 110 113 10.1126/science.285.5424.110 10390360
Sabui S. K. Venkateswaran R. V. Synthesis of O-methyl epi-heliannuol E Tetrahedron 2003 59 8375 8381 10.1016/j.tet.2003.08.059
Vrijsen R. Everaert L. Boeye A. Antiviral activity of flavones and potentiation by ascorbate J. Gen. Virol. 1988 69 1749 1751 10.1099/0022-1317-69-7-1749 2839607
Vroljk J. M. Kaul A. Hansen B. E. Lohmann V. Haagmans B. L. Schalm S. W. Bartenschlager R. A repliconbased bioassay for the measurement of interferons in patients with chronic hepatitis C J. Virol. Methods 2003 110 201 209 10.1016/S0166-0934(03)00134-4 12798249
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.